Welcome to the Arizona CERT!
We are an independent research and education center whose mission is to improve therapeutic outcomes and reduce adverse events caused by drug interactions and drugs that prolong the QT interval, especially those affecting women. The Arizona CERT is a program of the Critical Path Institute in collaboration with The University of Arizona College of Pharmacy. We are one of 14 national CERTs funded by the U.S. Agency for Healthcare Research and Quality (AHRQ).
Professional Resources
Consumer Resources
ALERT: Trazodone added to our list of drugs with Conditional Risk of Torsades de Pointes on March 30, 2010.
Trazodone is an antidepressant drug used to treat major depression and insomnia.
You are the most important member of your healthcare team!
Keep track of all your medicines. Click here to see a public service message from Richard Carmona, MD, MPH, FACS, 17th Surgeon General of the U.S.
